HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION

Highlights HPGC Renmintongtai Pharmaceutical Corporation

Equities

600829

CNE000000G05

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
6.4 ^CNY	-2.14%		-5.74%	-18.16%

19/04	HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
27/03	HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	27/03	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	11/23/11	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	20/23/20	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2022	24/22/24	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2022	12/22/12	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	20/22/20	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2021	15/21/15	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2021	06/21/06	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	19/21/19	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	19/21/19	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2020	16/20/16	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2020	14/20/14	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020	17/20/17	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	10/20/10	CI
HPGC Renmintongtai Pharmaceutical Corporation Approves Amending of Articles of Association	12/19/12	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2019	18/19/18	CI
Harbin Pharmaceutical Group Holding Co., Ltd. made an offer to acquire minority stake in HPGC Renmintongtai Pharmaceutical Corporation for CNY 0.02 million.	25/19/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights HPGC Renmintongtai Pharmaceutical Corporation

Equities

600829

CNE000000G05

Highlights

Filters